Pharmaceutical Preparations: Clinical Trials

59 trials of Pharmaceutical Preparations, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

38 completed, 7 unknown, 5 not yet recruiting, 3 active not recruiting. 59 Phase 3, 12 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 359Completed 38, Unknown 7, Not yet recruiting 5, Active not recruiting 3, Terminated 3, Withdrawn 2, Recruiting 1
Phase 212Completed 9, Not yet recruiting 1, Terminated 1, Unknown 1

Follow Pharmaceutical Preparations: new trials by email Literature Review of Pharmaceutical Preparations trials Research Report on Pharmaceutical Preparations

Trials (filtered) newest first · largest first

All 59 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders
Rifaximin (drug), Placebo - Bloating, Rifaximin
Phase 3Not yet recruitingMahidol University782026-12-012026-10-27
Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation
Ketofol, propofol (drug) - The Critically Ill Patient is Requiring Intubation, Septic Shock
Phase 3Active not recruitingHelwan University702026-05-132026-10-15
A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
Apatinib, Camrelizumab, TACE - Hepatocellular Carcinoma
Phase 2 / Phase 3Not yet recruitingShanghai Zhongshan Hospital2222025-12-222025-12-30
Trial to Assess the Efficacy and Safety During Convective Radiofrequency Water Vapor Thermal Therapy (REZUM) for Benign Prostate Hyperplasia
Methoxyflurane - Penthrox, Control, Percocet Pill - Benign Prostate Hypertrophy(BPH)
Phase 3Not yet recruitingUniversity of Manitoba482025-08-012025-06-12
Comparison of Bupivacaine Wound Infiltration Versus Wound Instillation to Minimize Postoperative Pain After Thyroid Surgery
Bupivacaine, Adrenaline, Lidocaine (drug) - Thyroid Surgery
Phase 3Not yet recruitingAssiut University1022025-03-012025-01-23
Comparsion of Intravenous Injection of Magnesium Sulfate and Lidocaine Effectiveness on the Prevention of Laryngospasm and Analgesic Requirement in Tonsillectomy
magnsium sulfate, Lidocaine (drug), Saline - Tonsillectomy
Phase 3Not yet recruitingAssiut University902025-03-012025-01-07
A Study of BGM0504 in Participants With Type 2 Diabetes
Drug: 5 mg BGM0504 Administered SC, Drug:10 mg BGM0504 Administered SC, Drug: Semaglutide Administered SC - Type 2 Diabetes Mellitus (T2DM)
Phase 3Active not recruitingBrightGene Bio-Medical Technology Co., Ltd.5372025-01-132026-10-15
A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
Drug: 5 mg BGM0504 Administered SC, Drug: : 10 mg BGM0504 Administered SC, Drug: Placebo Administered SC - Type 2 Diabetes Mellitus (T2DM)
Phase 3Active not recruitingBrightGene Bio-Medical Technology Co., Ltd.2072025-01-032026-10-15
Prophylactic IV Paracetamol in Extremely Premature Infants
Paracetamol (drug) - Patent Ductus Arteriosus in Preterm Infants, Patent Ductus Arteriosus After Premature Birth
Phase 2 / Phase 3CompletedAl-Quds University402025-01-012026-04-07
DEB-TACE+HAIC vs. HAIC for Large HCC
dTACE-HAIC, HAIC, dTACE-HAIC protocol - Unresectable Hepatocellular Carcinoma
Phase 3UnknownSecond Affiliated Hospital of Guangzhou Medical University2302022-02-102023-06-22
Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
Drug Capsule (Valsartan + Amlodipine + Rosuvastatin), Stroke Riskometer - Stroke, Cognitive Decline
Phase 3RecruitingHospital Moinhos de Vento85182021-12-202025-01-23
Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria
Lenvatinib, PD-1 antibody, TACE - Hepatocellular Carcinoma
Phase 3WithdrawnSun Yat-sen University2019-01-012019-05-02
Comparison of Topical Therapies in Post op Endoscopic Sinus Surgery Patients
Saline Nasal, Budesonide Nasal, Topical Antibacterial (Product) - Chronic Rhinosinusitis (Diagnosis)
Phase 3WithdrawnUniversity of Florida2018-04-012018-03-30
HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.
Hepatic arterial infusion chemotherapy, Transarterial chemoembolization, Folfox Protocol - HepatoCellular Carcinoma
Phase 3CompletedSun Yat-sen University3152016-10-012023-06-12
The Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Women
oral drug and vaginal placebo, oral drug and oral placebo, Vaginal placebo+ oral placebo - Infertility
Phase 3UnknownRoyan Institute602016-08-012020-10-06
Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)
HepQuant-SHUNT (Drug and Device) #65,123 (4D-cholate) and IND #65,121 (13C-cholate), Hepatic Venous Pressure Gradient (HVPG) - Liver Disease
Phase 3CompletedUniversity of Colorado, Denver202016-03-012021-08-09
Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis
PACK-CXL, Cefazolin in combination with either tobramycin or gentamicin, Cycloplegic agents (cyclopentolate 1% eye drops) - Keratitis; Infectious Disease (Manifestation)
Phase 3CompletedUniversity Hospital, Geneva352016-03-012020-10-20
PRF+1% MF for Class II Mandibular Furcation Defects
Open flap debridement (OFD), OFD with Platelet rich fibrin (PRF), OFD with Platelet rich fibrin (PRF)+1% Metformin (Drug) in gel form - Furcation Defects
Phase 2 / Phase 3CompletedGovernment Dental College and Research Institute, Bangalore752015-09-012017-07-05
Platelet Rich Fibrin+1% Alendronate in Treatment of Mandibular Degree II Furcation Defects
Open flap debridement (OFD), OFD with Platelet rich fibrin (PRF), OFD with Platelet rich fibrin (PRF)+1% Alendronate (Drug) in gel form - Furcation Defects
Phase 2 / Phase 3CompletedGovernment Dental College and Research Institute, Bangalore722015-01-012015-11-20
Platelet Rich Fibrin+1.2% Atorvastatin in Treatment of Mandibular Degree II Furcation Defects
Open flap debridement (OFD), OFD with Platelet rich fibrin (PRF), OFD with Platelet rich fibrin (PRF)+1.2% Atorvastatin (Drug) in gel form - Furcation Defects
Phase 2 / Phase 3CompletedGovernment Dental College and Research Institute, Bangalore822014-12-012015-11-24

Showing 20 of 59. Sign in to see all of them.

Conditions studied

Carcinoma, Hepatocellular (4)  ·  Furcation Defects (3)  ·  HIV Infections (3)  ·  Colitis, Ulcerative (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Dyslipidemias (2)  ·  Glucose Metabolism Disorders (2)  ·  Migraine Disorders (2)  ·  Surgical Wound Infection (2)  ·  Tourette Syndrome (2)  ·  Abdominal Pain (1)  ·  Acne Vulgaris (1)  ·  Amyloidosis (1)  ·  Arthritis, Rheumatoid (1)  ·  Bipolar Disorder (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (3)  ·  Government Dental College and Research Institute, Bangalore (3)  ·  Assiut University (2)  ·  Baylor College of Medicine (2)  ·  BrightGene Bio-Medical Technology Co., Ltd. (2)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (2)  ·  Solvay Pharmaceuticals (2)  ·  Sun Yat-sen University (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Advancis Pharmaceutical Corporation (1)  ·  Al-Quds University (1)  ·  Albert Einstein Healthcare Network (1)  ·  AstraZeneca (1)  ·  B. Braun Melsungen AG (1)

Countries

United States (14)  ·  France (9)  ·  Canada (6)  ·  China (6)  ·  Germany (4)  ·  India (4)  ·  United Kingdom (4)  ·  Italy (3)  ·  Poland (3)  ·  Russia (3)  ·  Belgium (2)  ·  Brazil (2)  ·  Egypt (2)  ·  Israel (2)  ·  Lithuania (2)

Top investigators

Genevieve Chene, MD, PhD (2)  ·  Joseph Jankovic, MD (2)  ·  Ming Shi, MD (2)  ·  Amanda Wieland, MD (1)  ·  Anand V Sahai, MD (1)  ·  Bruno Brochet, Professor (1)  ·  Catherine Thieblemont, MD (1)  ·  Charles J Fasano, DO (1)  ·  Christophe Vinsonneau, MD (1)  ·  Dominique Emilie, MD (1)  ·  Emanuele Zucca, MD (1)  ·  Emilio Montserrat, MD (1)

Results publications

PMID 15717256, PMID 16495395, PMID 17119142, PMID 17554116, PMID 17638804, PMID 18461895, PMID 18702902, PMID 19128645, PMID 20122369, PMID 20843990, PMID 21036772, PMID 21060071, PMID 21607551, PMID 21704313, PMID 22030902, PMID 22235871, PMID 22311838, PMID 22585216, PMID 22980682, PMID 23295789, PMID 23559535, PMID 23776108, PMID 24119597, PMID 24330904, PMID 25832968, PMID 26363164, PMID 27440128, PMID 27466854, PMID 27556896, PMID 27712462, PMID 28045953, PMID 28124652, PMID 29188298, PMID 29767684, PMID 31074236, PMID 32557558, PMID 34648352, PMID 34996516, PMID 37801707, PMID 40302359

NIH funding

2005 (1), UL1TR001082 (1)